Want to see ATXI full AI Analyst Report?
Avenue Therapeutics (ATXI) Ratios
Avenue Therapeutics Ratios
ATXI's free cash flow for Q2 2026 was $-475.00K. For the 2026 fiscal year, ATXI's free cash flow was increased by $0.00 and operating cash flow was $-475.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.60 | 3.27 | 1.55 | 1.91 | 7.78 |
| Quick Ratio | 2.60 | 3.27 | 1.55 | 1.91 | 7.78 |
| Cash Ratio | 2.60 | 3.18 | 1.49 | 1.87 | 7.39 |
| Solvency Ratio | -2.65 | -14.28 | 3.48 | -0.99 | 0.01 |
| Operating Cash Flow Ratio | -1.67 | -11.06 | -7.90 | -2.12 | -7.37 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 1.76M | $ 1.86M | $ 654.00K | $ 3.27M | $ 3.45M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.60 | 0.96 | 1.17 | 1.75 | 1.15 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | -2.11 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -6.93 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 39.81 | 0.00 |
| Net Debt to EBITDA | 0.87 | 0.22 | -0.44 | 2.75 | -537.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -234.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -234.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -234.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -209.90% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -207.19% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -209.90% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 98.71% | 99.62% | 98.94% | 98.58% | 100.00% |
| EBT Per EBIT | 89.68% | 103.66% | 72.13% | 44.80% | 99.81% |
| Return on Assets (ROA) | -99.25% | -436.08% | -560.92% | -51.89% | -94.22% |
| Return on Equity (ROE) | -158.79% | -416.59% | -655.94% | -90.96% | -108.11% |
| Return on Capital Employed (ROCE) | -179.37% | -607.92% | -2223.24% | -246.26% | -108.32% |
| Return on Invested Capital (ROIC) | -187.13% | -607.92% | -2016.64% | -246.26% | -108.32% |
| Return on Tangible Assets | -99.25% | -436.08% | -560.92% | -51.89% | -94.22% |
| Earnings Yield | -136.59% | -44.98% | -609.74% | -140.13% | -0.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.59 | -0.70 | -67.03 | -260.72 | -3.31 |
| Free Cash Flow Per Share | -0.59 | -0.70 | -88.30 | -260.72 | -3.31 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -3.15 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -3.15 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -1.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -86.06% | -34.84% | -731.61% | -299.68% | -0.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.73 | -2.22 | -0.16 | -0.71 | -310.20 |
| Price-to-Sales (P/S) Ratio | 1.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.16 | 9.26 | 1.08 | 0.65 | 335.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.16 | -2.87 | -0.14 | -0.33 | -308.63 |
| Price-to-Operating Cash Flow Ratio | -1.16 | -2.87 | -0.18 | -0.33 | -308.63 |
| Price-to-Earnings Growth (PEG) Ratio | -0.22 | 0.02 | 0.00 | -0.00 | 10.61 |
| Enterprise Value Multiple | 0.22 | -1.99 | -0.02 | 1.71 | 164799.50 |
| Enterprise Value | -725.20K | 23.31M | -81.13K | -4.17M | 1.15B |
| EV to EBITDA | 0.22 | -1.99 | -0.02 | 1.71 | 164799.50 |
| EV to Sales | -0.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.40 | -2.58 | 0.01 | 0.55 | -307.63 |
| EV to Operating Cash Flow | 0.40 | -2.58 | 0.01 | 0.55 | -307.63 |
| Tangible Book Value Per Share | 0.59 | 0.14 | 4.64 | 112.10 | 3.05 |
| Shareholders’ Equity Per Share | 0.59 | 0.22 | 11.22 | 134.03 | 3.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.93 | -0.90 | -73.60 | -121.92 | -3.29 |
| Tax Burden | 0.99 | 1.00 | 0.99 | 0.99 | 1.00 |
| Interest Burden | 0.90 | 1.00 | 1.00 | 1.47 | 1.00 |
| Research & Development to Revenue | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 2.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.63 | 0.77 | 0.91 | 2.11 | 1.01 |
Currency in USD
